Headlines AfricaApr 25, 2025
Africa: Price of Key DR-TB Medicine Drops 25% as TB Alliance's Multi-Manufacturer Strategy Expands Access: [allAfrica] TB Alliance's third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving affordability and access http://newsfeed.facilit8.network/TKMWNX #TBAlliance #DRTB #HealthAccess #GlobalHealth #AffordableMedications
ehwozaAug 30, 2024
[DailyRead] A new #TB pill just cleared a South African trial, showing it’s safe, effective, and could change the game in treating the disease. #DRTB #BEATtuberculosis #SouthAfrica https://www.timeslive.co.za/news/south-africa/2024-08-28-trial-shows-exciting-new-tb-oral-regimen-is-safe-and-effective/#google_vignette
Trial shows exciting new TB oral regimen is safe and effective

A groundbreaking initiative known as BEAT Tuberculosis has become the world's first initiative in the fight against drug-resistant tuberculosis (DR-TB) for all population groups, influencing the World Health Organization policy on treating TB internationally.

TimesLIVE
IndiaNewsWatchApr 2, 2024

For second time in seven months, India is running short of TB drugs, putting patients at risk

The Centre, which is responsible for supplying the medicines, has asked states to arrange medicines locally.

#health #tuberculosis #TB #TBDrugs #4FDC #3FDC #DRTB #DrugResistantTB #CMSS #HealthMinistry #UnionGovt #india

https://scroll.in/article/1066080/for-second-time-in-seven-months-india-is-running-short-of-tb-drugs-putting-patients-at-risk

For second time in seven months, India is running short of TB drugs, putting patients at risk

The Centre, which is responsible for supplying the medicines, has asked states to arrange medicines locally.

Scroll.in
IndiaNewsWatchOct 1, 2023

After Decades of Pressure, US Drugmaker J&J Gives Up Patent on Life-Saving TB Drug

This move can lead to the entry of many manufacturers of bedaquiline, thereby reducing the exorbitant price which many governments currently find difficult to afford for all of their patients, say activists.

https://thewire.in/health/after-decades-of-pressure-us-drugmaker-jj-gives-up-patent-on-life-saving-tb-drug

#tuberculosis #JohnsonAndJohnson #bedaquiline #sirturo #DrugResistantTB #DRTB #LMICs #DrugPatents #drugs #medicine #health #healthcare #india

After Decades of Pressure, US Drugmaker J&J Gives Up Patent on Life-Saving TB Drug

This move can lead to the entry of many manufacturers of bedaquiline, thereby reducing the exorbitant price which many governments currently find difficult to afford for all of their patients, say activists.

The Wire
IndiaNewsWatchSep 27, 2023

'Disregards Struggles': Civil Society Groups Slam Govt's Denial of TB Drugs Shortage

Ministry of health claims the required drugs of TB patients are available for six months. Civil Society groups calculations show they are not there even for three months.

https://thewire.in/health/civil-society-groups-slam-health-ministry-denial-tb-drugs-shortage

#tuberculosis #TBDrugs #DrugResistantTB #DRTB #health #healthcare #UnionGovt #medicine #WHO #india

'Disregards Struggles': Civil Society Groups Slam Govt's Denial of TB Drugs Shortage

Ministry of health claims the required drugs of TB patients are available for six months. Civil Society groups calculations show they are not there even for three months.

The Wire
IndiaNewsWatchSep 24, 2023

Unprecedented TB Drugs Stock-Out in India: Union Health Minister Skips UN High-Level Meet

'The Wire' spoke to several individuals across India, who are affected by the acute shortage of TB drugs in the country. The WHO has described this situation as 'worrying', while the state TB officials call it 'frustrating'.

https://thewire.in/health/will-the-un-high-level-meeting-address-indias-problem-of-tb-drugs-stock-out-situation

#tuberculosis #TB #TBDrugs #UN #WHO #MansukhMandaviya #DRTB #StopTBPartnership #GlobalTBProgramme #healthcare #health #medicine #india

Unprecedented TB Drugs Stock-Out in India: Union Health Minister Skips UN High-Level Meet

'The Wire' spoke to several individuals across India, who are affected by the acute shortage of TB drugs in the country. The WHO has described this situation as 'worrying', while the state TB officials call it 'frustrating'.

The Wire